Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1388.80
5.80 (0.42%) Cipla - Quaterly Results
Date: 29-10-2024
The Revenue for the quarter ended September 2024 of Rs. 47750.30 millions grew by 12.77 % from Rs. 42344.40 millions.Net Profit recorded in the quarter ended September 2024 rise to 28.68% to Rs. 11781.60 millions compared to R. 9155.40 millions in corresponding previous quarter.OP of the company witnessed a marginal growth to 17271.80 millions from 14304.70 millions in the same quarter last year.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202409 | 202309 | % Var | 202409 | 202309 | % Var | 202403 | 202303 | % Var | |
| Sales | 47750.30 | 42344.40 | 12.77 | 92760.80 | 81563.40 | 13.73 | 165743.40 | 143453.40 | 15.54 |
| Other Income | 2891.40 | 2050.90 | 40.98 | 5026.60 | 3630.70 | 38.45 | 10706.60 | 4567.90 | 134.39 |
| PBIDT | 17271.80 | 14304.70 | 20.74 | 33005.60 | 26646.60 | 23.86 | 55548.10 | 38096.80 | 45.81 |
| Interest | 30.00 | 66.10 | -54.61 | 80.70 | 69.20 | 16.62 | 202.50 | 222.70 | -9.07 |
| PBDT | 17241.80 | 14238.60 | 21.09 | 32924.90 | 26577.40 | 23.88 | 55345.60 | 36015.10 | 53.67 |
| Depreciation | 1457.10 | 1798.10 | -18.96 | 2835.70 | 3157.60 | -10.19 | 5875.90 | 5959.10 | -1.40 |
| PBT | 15784.70 | 12440.50 | 26.88 | 30089.20 | 23419.80 | 28.48 | 49469.70 | 30056.00 | 64.59 |
| TAX | 4003.10 | 3285.10 | 21.86 | 7748.20 | 6275.60 | 23.47 | 12327.80 | 8615.40 | 43.09 |
| Deferred Tax | -64.20 | -13.00 | 393.85 | 101.70 | -102.50 | -199.22 | 60.90 | -400.90 | -115.19 |
| PAT | 11781.60 | 9155.40 | 28.68 | 22341.00 | 17144.20 | 30.31 | 37141.90 | 21440.60 | 73.23 |
| Equity | 1615.10 | 1614.70 | 0.02 | 1615.10 | 1614.70 | 0.02 | 1614.70 | 1614.30 | 0.02 |
| PBIDTM(%) | 36.17 | 33.78 | 7.07 | 35.58 | 32.67 | 8.91 | 33.51 | 26.56 | 26.20 |